SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001427570-20-000033
Filing Date
2020-05-12
Accepted
2020-05-12 17:08:41
Documents
3
Period of Report
2020-05-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kq110xqextension.htm 8-K 45803
2 EXHIBIT 99.1 ex991pressrelease5820.htm EX-99.1 9137
3 EXHIBIT 99.2 ex992pressrelease51120.htm EX-99.2 11518
  Complete submission text file 0001427570-20-000033.txt   67739
Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008
Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400
OBALON THERAPEUTICS INC (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 20869996
SIC: 3841 Surgical & Medical Instruments & Apparatus